PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: PlacidWay

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PlacidWay Furthers Relationship with Panama-Based Stem Cell Facility - PlacidWay continues their relationship with Stem Cell Panama, focusing on stem cell and regenerative medicine in Panama City, Panama - PlacidWay.com
PlacidWay Furthers Relationship with Panama-Based Stem Cell Facility

 

NewswireToday - /newswire/ - Castle Pines, CO, United States, 2013/05/07 - PlacidWay continues their relationship with Stem Cell Panama, focusing on stem cell and regenerative medicine in Panama City, Panama - PlacidWay.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

PlacidWay continues to develop relations with Stem Cell and Regenerative Medicine Panama, a facility located in Panama City, Panama. The facility focuses on regenerative medicine through the use of stem cells, and also provides treatments for Parkinson's disease, diabetes, arthrosis, joints pain, rheumatism, multiple sclerosis, autism and other metabolic conditions.

The Panama-based stem cell facility focuses on applied research when it comes to regenerative medicine specializing in stem cell therapies. The latest advances in stem cell technologies enable Stem Cell Panama to focus on treatments that restore function and repair structures in damaged cellular tissues as well as organs. “Due to the aging process, renewable and repairable tissues grow increasingly limited with age, and therefore, regenerative medicine and its therapies focus on restoration of such tissues and organs in the body as we age,” states Dr. Esteban Estrada, scientific adviser with Stem Cell Panama. "Stem cell Panama focuses stem cell therapies to treat cardiovascular, osteo- articular and rheumatology disease processes.”

"Neurological diseases such as Parkinson's disease, multiple sclerosis, Alzheimer's, and damage caused to neurological systems as a result of stroke are also a main area of focus," states Pramod Goel, CEO and founder of PlacidWay, a leader in medical resources and providers based in Denver, Colorado. "Options with stem cell therapies include transplantation of mother cells, orthomolecular and hyperbaric medicine."

Stem cell therapies and methods for the treatment of Type 2 diabetes as well as preparation and rejuvenation of nervous system pathways as a result of trauma are also a major focus of stem cell Panama. Dr. Esteban Estrada is a specialist in cardiology and cardiovascular disease, and his studies and research are focused on regenerative medicine and in experimental phases of stem cell regenerative medicine and research, as well as research protocols based on quality clinical practices.

Panama provides travelers with beautiful destinations, accommodations, and entertainment venues, home to tropical rain forests, miles of Pacific and Caribbean coastline and beach activities, and numerous full-service resorts. Panama was chosen by the New York Times as the number one place to travel in 2012.

About PlacidWay

PlacidWay (placidway.com) is a leader in the medical tourism industry, dedicated to offering accurate, up-to-date information and resources regarding medical travel, international providers, treatments, procedures and destinations for international travelers.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PlacidWay

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


PlacidWay Furthers Relationship with Panama-Based Stem Cell Facility

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Pramod Goel - PlacidWay.com 
303-317-3607 info[.]placidway.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PlacidWay securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PlacidWay / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)